Bon Natural Life Limited, a Cayman Islands-incorporated, China-based natural-ingredients and fragrance compounds manufacturer operating through its Xi'an App-Chem subsidiary and headquartered in the High-Tech Zone of Xi'an, Shaanxi, filed its annual report on Form 20-F for the fiscal year ended September 30, 2025 in late January 2026, and the most recent disclosure shows that the company has been navigating a multi-year revenue decline. Total revenue of $18.67 million in fiscal 2025 was down from $23.84 million in fiscal 2024 and $29.52 million in fiscal 2023, a meaningful two-year revenue contraction of 36.8 percent that reflects both the customer concentration and the broader natural-ingredients market dynamics. The strategic implication is that the company is in the middle of a multi-year revenue contraction that has been a meaningful drag on the operating results, and the company has been responding through both the cost-rationalization efforts and the strategic divestiture of the Gansu subsidiary.
The principal question for the next several quarters is whether the company can stabilize the natural-ingredients and fragrance compounds franchise in the post-pandemic normalization environment, and whether the strategic divestiture of the Gansu subsidiary will produce a meaningful operating margin inflection. The disclosure cadence that the next twelve months resolve is, in order of importance, the half-year 2026 revenue and net loss trajectory in the next 6-K interim financial report, the customer concentration trajectory and the broader natural-ingredients market dynamics, the strategic divestiture progression of the Gansu subsidiary, the China-based VIE structure regulatory environment, and the cash position and the operating cash burn.